Lupus Erythematosus, Cutaneous
"Lupus Erythematosus, Cutaneous" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A form of lupus erythematosus in which the skin may be the only organ involved or in which skin involvement precedes the spread into other body systems. It has been classified into three forms - acute (= LUPUS ERYTHEMATOSUS, SYSTEMIC with skin lesions), subacute, and chronic (= LUPUS ERYTHEMATOSUS, DISCOID).
| Descriptor ID |
D008178
|
| MeSH Number(s) |
C17.300.475 C17.800.480
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Lupus Erythematosus, Cutaneous".
Below are MeSH descriptors whose meaning is more specific than "Lupus Erythematosus, Cutaneous".
This graph shows the total number of publications written about "Lupus Erythematosus, Cutaneous" by people in this website by year, and whether "Lupus Erythematosus, Cutaneous" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2006 | 1 | 0 | 1 |
| 2008 | 1 | 0 | 1 |
| 2009 | 1 | 0 | 1 |
| 2011 | 1 | 0 | 1 |
| 2014 | 1 | 0 | 1 |
| 2015 | 1 | 0 | 1 |
| 2016 | 1 | 0 | 1 |
| 2018 | 1 | 0 | 1 |
| 2019 | 2 | 0 | 2 |
| 2020 | 3 | 0 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Lupus Erythematosus, Cutaneous" by people in Profiles.
-
Factors associated with quality of life in cutaneous lupus erythematosus using the Revised Wilson and Cleary Model. Lupus. 2020 Nov; 29(13):1691-1703.
-
Evaluating change in disease activity needed to reflect meaningful improvement in quality of life for clinical trials in cutaneous lupus erythematosus. J Am Acad Dermatol. 2021 Jun; 84(6):1562-1567.
-
Principal components analysis as a tool to identify lesional skin patterns in cutaneous lupus erythematosus. J Am Acad Dermatol. 2020 Sep; 83(3):922-924.
-
A double-blind, randomized, placebo-controlled, phase II trial of baricitinib for systemic lupus erythematosus: how to optimize lupus trials to examine effects on cutaneous lupus erythematosus. Br J Dermatol. 2019 05; 180(5):964-965.
-
Validation and reliability of a disease-specific quality-of-life measure in patients with cutaneous lupus erythematosus. Br J Dermatol. 2019 06; 180(6):1430-1437.
-
Incremental health care services and expenditures associated with depression among individuals with cutaneous lupus erythematosus (CLE). Lupus. 2018 Jun; 27(7):1107-1115.
-
A systematic review of patient-reported outcomes in patients with cutaneous lupus erythematosus. Br J Dermatol. 2017 Jan; 176(1):52-61.
-
Epigenome profiling reveals significant DNA demethylation of interferon signature genes in lupus neutrophils. J Autoimmun. 2015 Apr; 58:59-66.
-
Influence of smoking on disease severity and antimalarial therapy in cutaneous lupus erythematosus: analysis of 1002 patients from the EUSCLE database. Br J Dermatol. 2014 Sep; 171(3):571-9.
-
A systematic review of drug-induced subacute cutaneous lupus erythematosus. Br J Dermatol. 2011 Mar; 164(3):465-72.